Does the "TOOKIE Vest" Reduce Line Fall Out Rate in Children?

Manchester University NHS Foundation Trust40 enrolled

Overview

The objective of the trial is to assess whether the TOOKIE vest is an effective intervention in reducing line fall out. All oncology patients with a tunneled central line will be approached to participate in this study. Following informed consent they will be issued with a TOOKIE vest.

All oncology patients with a tunneled central line will be approached to participate in this study. Following informed consent they will be issued with a TOOKIE vest. Lines will be studied for the duration they are in situ. This will vary depending on the underlying diagnosis and treatment regime. One hundred central line insertions for oncology patients will be prospectively identified and be given the "TOOKIE Vest" to wear. Data will be collated for each group regarding age, gender, diagnosis, type of central access inserted, duration of line, reason for removal, in cases of infection the infected organism will be documented, date of each fall out.

Study Type

INTERVENTIONAL

Allocation

Purpose

SUPPORTIVE_CARE

Masking

NONE

Enrollment

Conditions

Childhood Cancer

Interventions

Tookie VestDEVICE

Tookie Vest

Eligibility

Sex: ALLMin age: 0 YearsMax age: 16 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Any child receiving treatment for malignancy at Royal Manchester Children's Hospital * Patients with a tunnelled central line inserted for treatment of their malignancy Exclusion Criteria: • Any child having a portacath inserted as their mode of central access

Locations (1)

Manchester University NHS Foundation Trust

Manchester, United Kingdom

Outcomes

Primary Outcomes

Central line fall out rate

Time frame: approximately 1 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.